The Enterprise Value as of December 2025 (TTM) for Concert Pharmaceuticals, Inc. (CNCE) is -126571000.00

According to Concert Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -126571000.00. This represents a change of -244.18% compared to the average of 87.78M of the last 4 quarters.

Concert Pharmaceuticals, Inc. (CNCE) Historical Enterprise Value (quarterly & annually)

How has CNCE Enterprise Value performed in the past?

The mean historical Enterprise Value of Concert Pharmaceuticals, Inc. over the last ten years is 236.94M. The current -126571000.00 Enterprise Value has changed -5441.89% with respect to the historical average. Over the past ten years (40 quarters), CNCE's Enterprise Value was at its highest in in the December 2017 quarter at 564.99M. The Enterprise Value was at its lowest in in the December 2021 quarter at -28196100.00.

Concert Pharmaceuticals, Inc. (CNCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Concert Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Concert Pharmaceuticals, Inc. (CNCE) Average Enterprise Value

How has CNCE Enterprise Value performed in the past?

The current Enterprise Value of Concert Pharmaceuticals, Inc. (CNCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Concert Pharmaceuticals, Inc. (CNCE) Enterprise Value vs. Peers

How is CNCE’s Enterprise Value compared to its peers?

Concert Pharmaceuticals, Inc.’s Enterprise Value is less than Orchard Therapeutics plc (369.77M), less than Revance Therapeutics, Inc. (805.89M), less than Vigil Neuroscience, Inc. (346.93M), less than Checkpoint Therapeutics, Inc. (334.68M), less than iTeos Therapeutics, Inc. (245.99M), less than Climb Bio, Inc. (184.83M), less than G1 Therapeutics, Inc. (402.64M), less than Y-mAbs Therapeutics, Inc. (332.06M), less than SomaLogic, Inc. (-23127083.00), less than scPharmaceuticals Inc. (313.84M),

Build a custom stock screener for Concert Pharmaceuticals, Inc. (CNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concert Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concert Pharmaceuticals, Inc. (CNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concert Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.